{"source": "EMA documents JSON (filtered)", "days": 3, "cutoff_utc": "2025-12-17T10:58:47.636715+00:00", "count": 200, "debug_skipped_str": 0, "debug_skipped_other": 0, "items": [{"id": "68248", "name": "Datroway : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-13T10:01:05Z", "last_update_date": "2025-12-17T15:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/datroway-epar-product-information_en.pdf"}, {"id": "68928", "name": "Datroway : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-06-24T15:20:38Z", "last_update_date": "2025-12-17T12:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/datroway-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "15182", "name": "Tasigna : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-29T02:09:00Z", "last_update_date": "2025-12-17T17:21:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tasigna-epar-product-information_en.pdf"}, {"id": "19599", "name": "Tasigna : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-10-08T02:09:00Z", "last_update_date": "2025-12-17T17:13:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tasigna-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71798", "name": "EMA/PE/0000181219: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for bedaquiline (fumarate) (Sirturo)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T11:30:47Z", "last_update_date": "2025-12-17T11:30:47Z", "reference_number": "EMADOC-1700519818-1775423", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181219-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-bedaquiline-fumarate-sirturo_en.pdf"}, {"id": "71799", "name": "EMA/PE/0000181236: EMA decision of 5 December 2024 on the granting of a product specific waiver for telisotuzumab conjugated to (2S)-2-(2-bromoacetamido)-N-[(2S)-1-({3-[(7S)-7-ethyl-7-hydroxy-8,11-dioxo-7,8,11,13-tetrahydro-2H,10H-[1,3]dioxolo[4,5-g] ...", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T11:48:05Z", "last_update_date": "2025-12-17T11:48:05Z", "reference_number": "EMADOC-1700519818-1791510", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181236-ema-decision-5-december-2024-granting-product-specific-waiver-telisotuzumab-conjugated-2s-2-2-bromoacetamido-n-2s-1-3-7s-7-ethyl-7-hydroxy-811-dioxo-781113-tetrahydro-2h10h_en.pdf"}, {"id": "14742", "name": "Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals): EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2011-12-21T01:00:00Z", "last_update_date": "2025-12-17T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/adjupanrix-previously-pandemic-influenza-vaccine-h5n1-split-virion-inactivated-adjuvanted-glaxosmithkline-biologicals-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71800", "name": "Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals): EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T12:04:29Z", "last_update_date": "2025-12-17T12:04:29Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/adjupanrix-previously-pandemic-influenza-vaccine-h5n1-split-virion-inactivated-adjuvanted-glaxosmithkline-biologicals-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71801", "name": "EMA/PE/0000181238: EMA decision of 6 December 2024 on the agreement of a paediatric investigation plan and on the granting of a waiver for resiquimod", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:07:40Z", "last_update_date": "2025-12-17T12:07:40Z", "reference_number": "EMADOC-1700519818-1775491", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181238-ema-decision-6-december-2024-agreement-paediatric-investigation-plan-granting-waiver-resiquimod_en.pdf"}, {"id": "71802", "name": "EMA/PE/0000181294: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for tolebrutinib", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:23:45Z", "last_update_date": "2025-12-17T12:23:45Z", "reference_number": "EMADOC-1700519818-1766802", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181294-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-tolebrutinib_en.pdf"}, {"id": "71803", "name": "EMA/PE/0000181300: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for avalglucosidase alfa (Nexviadyme)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:31:22Z", "last_update_date": "2025-12-17T12:31:22Z", "reference_number": "EMADOC-1700519818-1793517", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181300-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-avalglucosidase-alfa-nexviadyme_en.pdf"}, {"id": "71804", "name": "EMA/PE/0000221175 : EMA decision of 16 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for vibegron", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T12:57:00Z", "last_update_date": "2025-12-17T12:57:00Z", "reference_number": "EMADOC-1700519818-1807888", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221175-ema-decision-16-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-vibegron_en.pdf"}, {"id": "19866", "name": "QRD Appendix V - Adverse-drug-reaction reporting details", "type": "template-form", "status": "unknown", "consultation_date": "", "publish_date": "2013-03-15T17:00:00Z", "last_update_date": "2025-12-17T13:20:00Z", "reference_number": "EMA/67830/2013 Version 34", "url": "https://www.ema.europa.eu/en/documents/template-form/qrd-appendix-v-adverse-drug-reaction-reporting-details_en.docx"}, {"id": "56226", "name": "Agenda - ACT EU multi-stakeholder meeting on decentralised clinical trials", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2022-09-28T10:58:00Z", "last_update_date": "2025-12-17T15:50:00Z", "reference_number": "EMA/789028/2022", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-act-eu-multi-stakeholder-meeting-decentralised-clinical-trials_en.pdf"}, {"id": "71806", "name": "Oxbryta Article-20 procedure - Assessment report", "type": "referral", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:01:49Z", "last_update_date": "2025-12-17T14:01:49Z", "reference_number": "EMA/354175/2025", "url": "https://www.ema.europa.eu/en/documents/referral/oxbryta-article-20-procedure-assessment-report_en.pdf"}, {"id": "71807", "name": "EMA/PE/0000220986 : EMA decision of 6 December 2024 on the granting of a product specific waiver for tenapanor", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:15:21Z", "last_update_date": "2025-12-17T14:15:21Z", "reference_number": "EMADOC-1700519818-1793255 Corr", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000220986-ema-decision-6-december-2024-granting-product-specific-waiver-tenapanor_en.pdf"}, {"id": "71808", "name": "EMA/PE/0000221021 : EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for atazanavir (sulphate) / cobicistat (EVOTAZ)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:19:52Z", "last_update_date": "2025-12-17T14:19:52Z", "reference_number": "EMADOC-1700519818-1793575", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221021-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-atazanavir-sulphate-cobicistat-evotaz_en.pdf"}, {"id": "71809", "name": "EMA/PE/0000181335: EMA decision of 5 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for budesonide / glycopyrronium bromide / formoterol (fumarate) (Trixeo Aerosphere)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:21:24Z", "last_update_date": "2025-12-17T14:21:24Z", "reference_number": "EMADOC-1700519818-1791535", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181335-ema-decision-5-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-budesonide-glycopyrronium-bromide-formoterol-fumarate-trixeo-aerosphere_en.pdf"}, {"id": "71810", "name": "EMA/PE/0000181441: EMA decision of 6 December 2024 on the granting of a product specific waiver for telisotuzumab conjugated to (2S)-2-(2-bromoacetamido)-N-[(2S)-1-({3-[(7S)-7-ethyl-7-hydroxy-8,11-dioxo-7,8,11,13-tetrahydro-2H,10H-[1,3]dioxolo[4,5-g] ...", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:27:14Z", "last_update_date": "2025-12-17T14:27:14Z", "reference_number": "EMADOC-1700519818-1793529", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181441-ema-decision-6-december-2024-granting-product-specific-waiver-telisotuzumab-conjugated-2s-2-2-bromoacetamido-n-2s-1-3-7s-7-ethyl-7-hydroxy-811-dioxo-781113-tetrahydro-2h10h_en.pdf"}, {"id": "71811", "name": "EMA/PE/0000221101 : EMA decision of 5 December 2024 on the granting of a product specific waiver for esepapogene zalarnarepvec", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:29:02Z", "last_update_date": "2025-12-17T14:29:02Z", "reference_number": "EMADOC-1700519818-1791979", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221101-ema-decision-5-december-2024-granting-product-specific-waiver-esepapogene-zalarnarepvec_en.pdf"}, {"id": "71812", "name": "EMA/PE/0000181518: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for lerodalcibep", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:34:07Z", "last_update_date": "2025-12-17T14:34:07Z", "reference_number": "EMADOC-1700519818-1766926", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181518-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-lerodalcibep_en.pdf"}, {"id": "71813", "name": "EMA/PE/0000221751 : EMA decision of 5 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for ascorbic acid, macrogol 3350, potassium chloride, sodium ascorbate, sodium chloride, sodium sulphate (Plenvu)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:41:20Z", "last_update_date": "2025-12-17T14:41:20Z", "reference_number": "EMADOC-1700519818-1792265", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000221751-ema-decision-5-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-ascorbic-acid-macrogol-3350-potassium-chloride-sodium-ascorbate-sodium-chloride-sodium_en.pdf"}, {"id": "43389", "name": "Ocrevus : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2023-11-10T15:51:00Z", "last_update_date": "2025-12-17T16:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/ocrevus-epar-risk-management-plan_en.pdf"}, {"id": "68135", "name": "Ocrevus : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-06T18:32:15Z", "last_update_date": "2025-12-17T15:18:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ocrevus-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71814", "name": "EMA/PE/0000181778: EMA decision of 6 December 2024 on the granting of a product specific waiver for rilvegostomig", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T14:50:39Z", "last_update_date": "2025-12-17T14:50:39Z", "reference_number": "EMADOC-1700519818-1793273", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000181778-ema-decision-6-december-2024-granting-product-specific-waiver-rilvegostomig_en.pdf"}, {"id": "67249", "name": "Entyvio : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-03-13T12:16:27Z", "last_update_date": "2025-12-17T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/entyvio-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71815", "name": "EMA/PE/0000182170: EMA decision of 5 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for regorafenib (Stivarga)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:09:08Z", "last_update_date": "2025-12-17T15:09:08Z", "reference_number": "EMADOC-1700519818-1791595", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182170-ema-decision-5-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-regorafenib-stivarga_en.pdf"}, {"id": "71816", "name": "EMA/PE/0000182217: EMA decision of 6 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for cedazuridine / decitabine (Inaqovi)", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:15:58Z", "last_update_date": "2025-12-17T15:15:58Z", "reference_number": "EMADOC-1700519818-1789714", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182217-ema-decision-6-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-cedazuridine-decitabine-inaqovi_en.pdf"}, {"id": "71817", "name": "EMA/PE/0000182239: EMA decision of 19 December 2024 on the acceptance of a modification of an agreed paediatric investigation plan for setmelanotide (Imcivree) ", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:21:52Z", "last_update_date": "2025-12-17T15:21:52Z", "reference_number": "EMADOC-1700519818-1796893", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182239-ema-decision-19-december-2024-acceptance-modification-agreed-paediatric-investigation-plan-setmelanotide-imcivree_en.pdf"}, {"id": "71818", "name": "EMA/PE/0000182297: EMA decision of 6 December 2024 on the granting of a product specific waiver for oxybutynin", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:26:23Z", "last_update_date": "2025-12-17T15:26:23Z", "reference_number": "EMADOC-1700519818-1790205", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182297-ema-decision-6-december-2024-granting-product-specific-waiver-oxybutynin_en.pdf"}, {"id": "71819", "name": "EMA/PE/0000182333: EMA decision of 6 December 2024 on the granting of a product specific waiver for precemtabart tocentecan", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:32:37Z", "last_update_date": "2025-12-17T15:32:37Z", "reference_number": "EMADOC-1700519818-1789267", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182333-ema-decision-6-december-2024-granting-product-specific-waiver-precemtabart-tocentecan_en.pdf"}, {"id": "9718", "name": "Trumenba : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-06-06T02:00:00Z", "last_update_date": "2025-12-17T15:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/trumenba-epar-product-information_en.pdf"}, {"id": "67770", "name": "Trumenba : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-14T10:47:33Z", "last_update_date": "2025-12-17T16:29:38Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/trumenba-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71820", "name": "EMA/PE/0000182345: EMA decision of 6 December 2024 on the granting of a product specific waiver for inbakicept, nogapendekin alfa", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:40:57Z", "last_update_date": "2025-12-17T15:40:57Z", "reference_number": "EMADOC-1700519818-1790021", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000182345-ema-decision-6-december-2024-granting-product-specific-waiver-inbakicept-nogapendekin-alfa_en.pdf"}, {"id": "71821", "name": "Overview of (invented) names reviewed in November 2025 by the Name Review Group (NRG) adopted at the CHMP meeting of 11 December 2025", "type": "chmp-annex", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T15:58:28Z", "last_update_date": "2025-12-17T15:58:28Z", "reference_number": "EMA/394227/2025", "url": "https://www.ema.europa.eu/en/documents/chmp-annex/overview-invented-names-reviewed-november-2025-name-review-group-nrg-adopted-chmp-meeting-11-december-2025_en.pdf"}, {"id": "69085", "name": "Ziihera : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-03T10:50:07Z", "last_update_date": "2025-12-17T16:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/ziihera-epar-product-information_en.pdf"}, {"id": "71822", "name": "Ziihera : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:10:11Z", "last_update_date": "2025-12-17T16:10:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ziihera-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71823", "name": "Presentation - System Demo Q4 2025", "type": "presentation", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:09:39Z", "last_update_date": "2025-12-17T16:09:39Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/presentation/presentation-system-demo-q4-2025_en.pdf"}, {"id": "71824", "name": "Q&A - System Demo Q4 2025", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:11:23Z", "last_update_date": "2025-12-17T16:11:23Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/qa-system-demo-q4-2025_en.pdf"}, {"id": "71755", "name": "Concept Paper on the revision of Annex 3 of the guidelines on Good Manufacturing Practice for Radiopharmaceuticals", "type": "scientific-guideline", "status": "Draft: consultation open", "consultation_date": "2025-12-15 - 2026-02-15", "publish_date": "2025-12-15T11:41:06Z", "last_update_date": "2025-12-17T16:16:23Z", "reference_number": "EMA/INS/GMP/389655/2025", "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/concept-paper-revision-annex-3-guidelines-good-manufacturing-practice-radiopharmaceuticals_en.pdf"}, {"id": "71825", "name": "Shortage Prevention Plan (SPP) and Shortage Mitigation Plan (SMP) pilot report", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:19:26Z", "last_update_date": "2025-12-17T16:19:26Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/shortage-prevention-plan-spp-shortage-mitigation-plan-smp-pilot-report_en.pdf"}, {"id": "57218", "name": "Table of decisions of labelling exemption requests falling under article 63 of Directive 2001/83/EC examined by the Quality Review of Documents (QRD) Group", "type": "regulatory-procedural-guideline", "status": "unknown", "consultation_date": "", "publish_date": "2023-01-11T14:13:00Z", "last_update_date": "2025-12-17T13:22:00Z", "reference_number": "EMA/934543/2022 Rev.7", "url": "https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/table-decisions-labelling-exemption-requests-falling-under-article-63-directive-2001-83-ec-examined-quality-review-documents-qrd-group_en.pdf"}, {"id": "71561", "name": "Call for user acceptance testers for the read functionality in the Public Product Management Service (PMS) Application Programming Interface (API)", "type": "other", "status": "Draft: consultation open", "consultation_date": "2025-12-08 - 2026-01-12", "publish_date": "2025-12-08T09:32:29Z", "last_update_date": "2025-12-17T16:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/call-user-acceptance-testers-read-functionality-public-product-management-service-pms-application-programming-interface-api_en.pdf"}, {"id": "29593", "name": "List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2012-10-01T14:08:00Z", "last_update_date": "2025-12-17T16:30:00Z", "reference_number": "EMA/630645/2012 Rev. 155", "url": "https://www.ema.europa.eu/en/documents/other/list-european-union-reference-dates-eurd-frequency-submission-periodic-safety-update-reports-psurs_en.xlsx"}, {"id": "27249", "name": "Lucentis : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-08-20T02:00:00Z", "last_update_date": "2025-12-17T12:52:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/lucentis-epar-product-information_en.pdf"}, {"id": "27264", "name": "Lucentis : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-08-20T02:00:00Z", "last_update_date": "2025-12-17T12:53:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/lucentis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71827", "name": "Lucentis : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:35:49Z", "last_update_date": "2025-12-17T16:35:49Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/lucentis-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71828", "name": "Lucentis : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-17T16:37:39Z", "last_update_date": "2025-12-17T16:37:39Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/lucentis-epar-product-information-tracked-changes_en.docx"}, {"id": "71826", "name": "Mozobil : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-08-20T16:21:21Z", "last_update_date": "2025-12-17T16:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/mozobil-epar-product-information_en.pdf"}, {"id": "26168", "name": "Abilify Maintena : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2013-11-28T01:00:00Z", "last_update_date": "2025-12-18T15:16:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/abilify-maintena-epar-product-information_en.pdf"}, {"id": "70883", "name": "Abilify Maintena : EPAR – Product information – tracked changes ", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-28T14:07:56Z", "last_update_date": "2025-12-18T08:33:03Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/abilify-maintena-epar-product-information-tracked-changes_en.docx"}, {"id": "42179", "name": "Invokana : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2018-10-03T11:48:00Z", "last_update_date": "2025-12-18T11:54:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/invokana-epar-risk-management-plan_en.pdf"}, {"id": "9353", "name": "Invokana : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2013-11-29T01:00:00Z", "last_update_date": "2025-12-18T14:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/invokana-epar-product-information_en.pdf"}, {"id": "20433", "name": "Invokana : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2014-09-04T02:00:00Z", "last_update_date": "2025-12-18T11:56:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/invokana-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "31621", "name": "Invokana : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2013-11-29T01:00:00Z", "last_update_date": "2025-12-18T01:00:00Z", "reference_number": "EMA/277052/2025", "url": "https://www.ema.europa.eu/en/documents/overview/invokana-epar-medicine-overview_en.pdf"}, {"id": "71829", "name": "Invokana-H-C-002649-II-0069 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T08:49:34Z", "last_update_date": "2025-12-18T08:49:34Z", "reference_number": "EMA/273696/2025", "url": "https://www.ema.europa.eu/en/documents/variation-report/invokana-h-c-002649-ii-0069-epar-assessment-report-variation_en.pdf"}, {"id": "71830", "name": "Invokana : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T09:02:25Z", "last_update_date": "2025-12-18T09:02:25Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/invokana-epar-product-information-tracked-changes_en.docx"}, {"id": "70228", "name": "Alyftrek : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-23T13:54:19Z", "last_update_date": "2025-12-18T11:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/alyftrek-epar-product-information_en.pdf"}, {"id": "54706", "name": "Breyanzi : EPAR - Medicine Overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2022-04-08T15:22:00Z", "last_update_date": "2025-12-18T16:16:00Z", "reference_number": "EMADOC-1829012207-33599", "url": "https://www.ema.europa.eu/en/documents/overview/breyanzi-epar-medicine-overview_en.pdf"}, {"id": "54709", "name": "Breyanzi : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2022-04-08T15:31:00Z", "last_update_date": "2025-12-18T17:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/breyanzi-epar-risk-management-plan_en.pdf"}, {"id": "54707", "name": "Breyanzi : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-04-08T15:26:00Z", "last_update_date": "2025-12-18T12:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/breyanzi-epar-product-information_en.pdf"}, {"id": "67743", "name": "Breyanzi : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-11T08:28:20Z", "last_update_date": "2025-12-18T12:19:30Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/breyanzi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71831", "name": "Breyanzi-VR-0000265024 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T09:20:07Z", "last_update_date": "2025-12-18T09:20:07Z", "reference_number": "EMADOC-1700519818-2456442", "url": "https://www.ema.europa.eu/en/documents/variation-report/breyanzi-vr-0000265024-epar-assessment-report-variation_en.pdf"}, {"id": "71832", "name": "Breyanzi-H-C-004731-P46-023 : EPAR - Assessment report", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T09:22:37Z", "last_update_date": "2025-12-18T09:22:37Z", "reference_number": "EMA/500721/2024", "url": "https://www.ema.europa.eu/en/documents/variation-report/breyanzi-h-c-004731-p46-023-epar-assessment-report_en.pdf"}, {"id": "62259", "name": "Azacitidine Kabi: EPAR - Product Information ", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-02-22T14:51:44Z", "last_update_date": "2025-12-18T11:11:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/azacitidine-kabi-epar-product-information_en.pdf"}, {"id": "71833", "name": "Azacitidine Kabi : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T09:44:14Z", "last_update_date": "2025-12-18T09:44:14Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/azacitidine-kabi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "8802", "name": "Caelyx pegylated liposomal : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-03-09T01:00:00Z", "last_update_date": "2025-12-18T17:56:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/caelyx-pegylated-liposomal-epar-product-information_en.pdf"}, {"id": "69918", "name": "Caelyx pegylated liposomal : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-02T08:48:49Z", "last_update_date": "2025-12-18T09:50:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/caelyx-pegylated-liposomal-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "33324", "name": "Mepact : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-05-06T02:00:00Z", "last_update_date": "2025-12-18T14:35:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/mepact-epar-product-information_en.pdf"}, {"id": "69345", "name": "Mepact : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-17T11:49:56Z", "last_update_date": "2025-12-18T09:55:05Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/mepact-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71174", "name": "Alyftrek : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-14T11:10:29Z", "last_update_date": "2025-12-18T10:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/alyftrek-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "21436", "name": "Leflunomide ratiopharm : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2011-01-17T01:00:00Z", "last_update_date": "2025-12-18T13:11:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/leflunomide-ratiopharm-epar-product-information_en.pdf"}, {"id": "39696", "name": "Leflunomide ratiopharm : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2011-03-21T01:00:00Z", "last_update_date": "2025-12-18T13:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/leflunomide-ratiopharm-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71834", "name": "EMA/PE/0000232894 : EMA decision of 14 April 2025 on the agreement of a paediatric investigation plan and on the granting of a deferral for adeno-associated viral vector serotype 9 containing the human MECP2 gene", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T10:12:49Z", "last_update_date": "2025-12-18T10:12:49Z", "reference_number": "EMADOC-1700519818-2039246", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000232894-ema-decision-14-april-2025-agreement-paediatric-investigation-plan-granting-deferral-adeno-associated-viral-vector-serotype-9-containing-human-mecp2-gene_en.pdf"}, {"id": "71836", "name": "Minutes - Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 20 November 2025", "type": "minutes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T10:19:17Z", "last_update_date": "2025-12-18T10:19:17Z", "reference_number": "EMA/367781/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/minutes-executive-steering-group-shortages-safety-medicinal-products-mssg-20-november-2025_en.pdf"}, {"id": "71837", "name": "EMA/PE/0000232896 : EMA decision of 21 February 2025 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for antisense oligonucleotide against patatin like phospholipase....sodium salt", "type": "pip-decision", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T10:19:18Z", "last_update_date": "2025-12-18T10:19:18Z", "reference_number": "EMADOC-1700519818-1911730", "url": "https://www.ema.europa.eu/en/documents/pip-decision/ema-pe-0000232896-ema-decision-21-february-2025-agreement-paediatric-investigation-plan-granting-deferral-granting-waiver-antisense-oligonucleotide-against-patatin-phospholipasesodium-salt_en.pdf"}, {"id": "71838", "name": "Cosentyx-PAM-0000301644 : EPAR - Assessment report", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T10:26:26Z", "last_update_date": "2025-12-18T10:26:26Z", "reference_number": "EMADOC-1700519818-2769286", "url": "https://www.ema.europa.eu/en/documents/variation-report/cosentyx-pam-0000301644-epar-assessment-report_en.pdf"}, {"id": "59548", "name": "Ebymect : EPAR - Risk-management-plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2015-11-23T14:19:00Z", "last_update_date": "2025-12-18T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/ebymect-epar-risk-management-plan_en.pdf"}, {"id": "45348", "name": "Xigduo : EPAR - Risk Management Plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2023-05-26T14:19:00Z", "last_update_date": "2025-12-18T10:32:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/xigduo-epar-risk-management-plan_en.pdf"}, {"id": "47119", "name": "Qtern : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2020-03-25T14:46:00Z", "last_update_date": "2025-12-18T10:25:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/qtern-epar-risk-management-plan_en.pdf"}, {"id": "23191", "name": "Strimvelis : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2017-08-17T16:44:00Z", "last_update_date": "2025-12-18T16:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/strimvelis-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71839", "name": "Overview of comments received on \"Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations\"", "type": "comments", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T11:05:35Z", "last_update_date": "2025-12-18T11:05:35Z", "reference_number": "(EMA/CHMP/72790/2024)", "url": "https://www.ema.europa.eu/en/documents/comments/overview-comments-received-guideline-allergen-products-development-immunotherapy-allergy-diagnosis-moderate-low-sized-study-populations_en.pdf"}, {"id": "54235", "name": "Saphnelo : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-02-21T14:15:00Z", "last_update_date": "2025-12-18T15:16:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/saphnelo-epar-product-information_en.pdf"}, {"id": "54236", "name": "Saphnelo : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2022-02-21T14:17:00Z", "last_update_date": "2025-12-18T11:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/saphnelo-epar-all-authorised-presentations_en.pdf"}, {"id": "56429", "name": "Saphnelo : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2022-10-18T13:38:00Z", "last_update_date": "2025-12-18T15:17:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/saphnelo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "54237", "name": "Saphnelo : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2022-02-21T14:20:00Z", "last_update_date": "2025-12-18T13:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/saphnelo-epar-risk-management-plan_en.pdf"}, {"id": "71840", "name": "Saphnelo-H-C-004975-X-0023 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T11:56:09Z", "last_update_date": "2025-12-18T11:56:09Z", "reference_number": "EMA/348230/2025", "url": "https://www.ema.europa.eu/en/documents/variation-report/saphnelo-h-c-004975-x-0023-epar-assessment-report-variation_en.pdf"}, {"id": "66198", "name": "Absimky : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:14:51Z", "last_update_date": "2025-12-18T15:50:00Z", "reference_number": "EMA/536423/2024", "url": "https://www.ema.europa.eu/en/documents/overview/absimky-epar-medicine-overview_en.pdf"}, {"id": "66202", "name": "Absimky : EPAR - Risk Management Plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:23:35Z", "last_update_date": "2025-12-18T12:05:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/absimky-epar-risk-management-plan_en.pdf"}, {"id": "65325", "name": "CHMP summary of positive opinion for Absimky", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2024-10-18T12:00:00Z", "last_update_date": "2025-12-18T12:06:00Z", "reference_number": "EMA/CHMP/448121/2024 ", "url": "https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-absimky_en.pdf"}, {"id": "66201", "name": "Absimky : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2024-12-18T13:21:48Z", "last_update_date": "2025-12-18T12:06:00Z", "reference_number": "EMA/511029/2024", "url": "https://www.ema.europa.eu/en/documents/assessment-report/absimky-epar-public-assessment-report_en.pdf"}, {"id": "66200", "name": "Absimky : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:20:05Z", "last_update_date": "2025-12-18T19:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/absimky-epar-product-information_en.pdf"}, {"id": "66199", "name": "Absimky : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-18T13:18:45Z", "last_update_date": "2025-12-18T12:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/absimky-epar-all-authorised-presentations_en.pdf"}, {"id": "68505", "name": "Absimky : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-28T19:26:20Z", "last_update_date": "2025-12-18T11:00:02Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/absimky-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71841", "name": "Minutes of the PRAC meeting 27 - 30 October 2025", "type": "minutes", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T12:16:18Z", "last_update_date": "2025-12-18T12:16:18Z", "reference_number": "EMA/PRAC/375420/2025", "url": "https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-27-30-october-2025_en.pdf"}, {"id": "71805", "name": "Agenda - Management Board meeting: 17-18 December 2025", "type": "agenda", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-17T13:40:00Z", "last_update_date": "2025-12-18T12:20:29Z", "reference_number": "EMA/MB/331769/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-management-board-meeting-17-18-december-2025_en.pdf"}, {"id": "22425", "name": "Name Review Group form - questions and answers", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2013-01-24T12:10:00Z", "last_update_date": "2025-12-18T12:10:00Z", "reference_number": "EMA/741768/2012 Rev.1", "url": "https://www.ema.europa.eu/en/documents/other/name-review-group-form-questions-answers_en.pdf"}, {"id": "30832", "name": "Jentadueto : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2012-08-16T02:00:00Z", "last_update_date": "2025-12-18T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/jentadueto-epar-product-information_en.pdf"}, {"id": "68165", "name": "Jentadueto : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-08T11:50:56Z", "last_update_date": "2025-12-18T12:22:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/jentadueto-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "22982", "name": "Orgalutran : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2008-02-29T01:00:00Z", "last_update_date": "2025-12-18T17:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/orgalutran-epar-product-information_en.pdf"}, {"id": "32215", "name": "Orgalutran : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2008-02-29T01:00:00Z", "last_update_date": "2025-12-18T17:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/orgalutran-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71842", "name": "Orgalutran : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:28:12Z", "last_update_date": "2025-12-18T12:28:12Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/orgalutran-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71843", "name": "Orgalutran : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:30:12Z", "last_update_date": "2025-12-18T12:30:12Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/orgalutran-epar-product-information-tracked-changes_en.docx"}, {"id": "71844", "name": "Cetrotide : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:34:25Z", "last_update_date": "2025-12-18T12:34:25Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/cetrotide-epar-product-information-tracked-changes_en.docx"}, {"id": "17698", "name": "RotaTeq : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-12-04T00:09:00Z", "last_update_date": "2025-12-18T17:41:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/rotateq-epar-product-information_en.pdf"}, {"id": "67995", "name": "RotaTeq : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-25T16:26:37Z", "last_update_date": "2025-12-18T12:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/rotateq-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71845", "name": "Prazepam : List of nationally authorised medicinal products - PSUSA/00002502/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:57:21Z", "last_update_date": "2025-12-18T12:57:21Z", "reference_number": "EMADOC-1700519818-2770702", "url": "https://www.ema.europa.eu/en/documents/psusa/prazepam-list-nationally-authorised-medicinal-products-psusa-00002502-202503_en.pdf"}, {"id": "71846", "name": "Prazepam : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002502/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T12:58:59Z", "last_update_date": "2025-12-18T12:58:59Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/prazepam-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002502-202503_en.pdf"}, {"id": "71733", "name": "Questions and answers on the refusal of the marketing authorisation for Blarcamesine Anavex", "type": "smop-initial", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-18T13:25:00Z", "reference_number": "EMA/385732/2025", "url": "https://www.ema.europa.eu/en/documents/smop-initial/questions-answers-refusal-marketing-authorisation-blarcamesine-anavex_en.pdf"}, {"id": "71850", "name": "Fetcroja-PAM-0000303390 : EPAR - Assessment report", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T14:12:48Z", "last_update_date": "2025-12-18T14:12:48Z", "reference_number": "EMADOC-1700519818-2517542", "url": "https://www.ema.europa.eu/en/documents/variation-report/fetcroja-pam-0000303390-epar-assessment-report_en.pdf"}, {"id": "59513", "name": "List of medicines currently in PRIME scheme", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2016-10-17T17:41:00Z", "last_update_date": "2025-12-18T14:30:00Z", "reference_number": "EMA/521657/2016", "url": "https://www.ema.europa.eu/en/documents/other/list-medicines-currently-prime-scheme_en.xlsx"}, {"id": "71851", "name": "Recommendations on eligibility to PRIME scheme Adopted at the CHMP meeting of 8-11 December 2025", "type": "chmp-annex", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-18T14:27:07Z", "last_update_date": "2025-12-18T14:27:07Z", "reference_number": "EMA/371701/2025", "url": "https://www.ema.europa.eu/en/documents/chmp-annex/recommendations-eligibility-prime-scheme-adopted-chmp-meeting-8-11-december-2025_en.pdf"}, {"id": "71852", "name": "Summary of bilateral meeting: European Medicines Agency and the European Consumer Organisation (BEUC)", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T15:16:51Z", "last_update_date": "2025-12-18T15:16:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/summary-bilateral-meeting-european-medicines-agency-european-consumer-organisation-beuc_en.pdf"}, {"id": "71853", "name": "Agenda - EMA/BEUC Bilateral", "type": "agenda", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-18T15:18:11Z", "last_update_date": "2025-12-18T15:18:11Z", "reference_number": "EMA/230706/2025", "url": "https://www.ema.europa.eu/en/documents/agenda/agenda-ema-beuc-bilateral_en.pdf"}, {"id": "27303", "name": "Puregon : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-07-31T02:00:00Z", "last_update_date": "2025-12-18T17:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/puregon-epar-product-information_en.pdf"}, {"id": "70953", "name": "Puregon : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-30T17:19:06Z", "last_update_date": "2025-12-18T15:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/puregon-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "36387", "name": "Puregon : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2008-08-31T02:00:00Z", "last_update_date": "2025-12-18T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/puregon-epar-all-authorised-presentations_en.pdf"}, {"id": "66197", "name": "Afqlir : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-01-20T11:54:28Z", "last_update_date": "2025-12-18T15:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/afqlir-epar-product-information_en.pdf"}, {"id": "67963", "name": "Afqlir : EPAR -Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-24T16:52:28Z", "last_update_date": "2025-12-18T16:01:47Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/afqlir-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "57312", "name": "Pirfenidone Viatris : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2023-01-17T17:03:00Z", "last_update_date": "2025-12-19T18:14:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/pirfenidone-viatris-epar-product-information_en.pdf"}, {"id": "63476", "name": "Pirfenidone Viatris : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-06-04T14:00:00Z", "last_update_date": "2025-12-19T12:12:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/pirfenidone-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "64073", "name": "Altuvoct : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-07-12T11:11:01Z", "last_update_date": "2025-12-19T10:39:56Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/altuvoct-epar-product-information_en.pdf"}, {"id": "66065", "name": "Altuvoct : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-12-11T10:45:05Z", "last_update_date": "2025-12-19T08:22:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/altuvoct-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71854", "name": "Altuvoct : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:22:53Z", "last_update_date": "2025-12-19T08:22:53Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/altuvoct-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71855", "name": "Altuvoct-PSUSA-00011062-202502 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation", "type": "scientific-conclusion", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:23:31Z", "last_update_date": "2025-12-19T08:23:31Z", "reference_number": "EMADOC-1700519818-2767181", "url": "https://www.ema.europa.eu/en/documents/scientific-conclusion/altuvoct-psusa-00011062-202502-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf"}, {"id": "71856", "name": "Macitentan Accord : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:38:28Z", "last_update_date": "2025-12-19T08:38:28Z", "reference_number": "EMA/251911/2025", "url": "https://www.ema.europa.eu/en/documents/overview/macitentan-accord-epar-medicine-overview_en.pdf"}, {"id": "71857", "name": "Macitentan Accord : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:39:28Z", "last_update_date": "2025-12-19T08:39:28Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/macitentan-accord-epar-risk-management-plan_en.pdf"}, {"id": "71858", "name": "Macitentan Accord : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:40:31Z", "last_update_date": "2025-12-19T08:40:31Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/macitentan-accord-epar-product-information_en.pdf"}, {"id": "71859", "name": "Macitentan Accord : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T08:41:26Z", "last_update_date": "2025-12-19T08:41:26Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/macitentan-accord-epar-all-authorised-presentations_en.pdf"}, {"id": "71860", "name": "Macitentan Accord : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T08:42:29Z", "last_update_date": "2025-12-19T08:42:29Z", "reference_number": "EMA/CHMP/216790/2025", "url": "https://www.ema.europa.eu/en/documents/assessment-report/macitentan-accord-epar-public-assessment-report_en.pdf"}, {"id": "56060", "name": "Vyvgart : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2022-09-12T10:34:00Z", "last_update_date": "2025-12-19T12:38:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/vyvgart-epar-product-information_en.pdf"}, {"id": "71862", "name": "Varicella vaccine (live) : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010473/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:06:11Z", "last_update_date": "2025-12-19T09:06:11Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/varicella-vaccine-live-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00010473-202503_en.pdf"}, {"id": "71861", "name": "Varicella vaccine (live) : List of nationally authorised medicinal products - PSUSA/00010473/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:04:47Z", "last_update_date": "2025-12-19T09:04:47Z", "reference_number": "EMADOC-1700519818-2588438", "url": "https://www.ema.europa.eu/en/documents/psusa/varicella-vaccine-live-list-nationally-authorised-medicinal-products-psusa-00010473-202503_en.pdf"}, {"id": "71863", "name": "Varicella vaccine (live) : List of nationally authorised medicinal products - PSUSA/00010473/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:12:47Z", "last_update_date": "2025-12-19T09:12:47Z", "reference_number": "EMADOC-1700519818-2588438", "url": "https://www.ema.europa.eu/en/documents/psusa/varicella-vaccine-live-list-nationally-authorised-medicinal-products-psusa-00010473-202503_en.pdf-0"}, {"id": "47660", "name": "Ruconest : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2020-05-18T09:20:00Z", "last_update_date": "2025-12-19T13:45:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/ruconest-epar-risk-management-plan_en.pdf"}, {"id": "31810", "name": "Ruconest : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2011-10-14T02:00:00Z", "last_update_date": "2025-12-19T12:49:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ruconest-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71864", "name": "Ruconest : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T09:24:35Z", "last_update_date": "2025-12-19T09:24:35Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/ruconest-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "69781", "name": "Comirnaty : 3.2.P drug product", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-08-20T10:25:15Z", "last_update_date": "2025-12-19T11:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/comirnaty-32p-drug-product_en.zip"}, {"id": "71721", "name": "Questions and answers on the refusal of the marketing authorisation for Hetlioz X-39", "type": "smop", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-12T14:00:00Z", "last_update_date": "2025-12-19T11:30:00Z", "reference_number": "EMEA/H/C/003870/X/0039", "url": "https://www.ema.europa.eu/en/documents/smop/questions-answers-refusal-marketing-authorisation-hetlioz-x-39_en.pdf"}, {"id": "69922", "name": "Comirnaty : 3.2.S Drug substance", "type": "other", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-02T09:31:43Z", "last_update_date": "2025-12-19T11:28:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/other/comirnaty-32s-drug-substance_en.zip"}, {"id": "71866", "name": "Methylthioninium chloride Proveblue : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T11:32:51Z", "last_update_date": "2025-12-19T11:32:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/methylthioninium-chloride-proveblue-epar-risk-management-plan_en.pdf"}, {"id": "20098", "name": "Methylthioninium chloride Proveblue : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2012-02-28T01:00:00Z", "last_update_date": "2025-12-19T17:21:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/methylthioninium-chloride-proveblue-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71867", "name": "Methylthioninium chloride Proveblue : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T11:36:13Z", "last_update_date": "2025-12-19T11:36:13Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/methylthioninium-chloride-proveblue-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "16662", "name": "Methylthioninium chloride Proveblue : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2011-06-06T02:00:00Z", "last_update_date": "2025-12-19T17:19:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/methylthioninium-chloride-proveblue-epar-product-information_en.pdf"}, {"id": "26375", "name": "Simulect : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2008-10-31T01:00:00Z", "last_update_date": "2025-12-19T11:51:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/simulect-epar-product-information_en.pdf"}, {"id": "35844", "name": "Simulect : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2008-10-31T01:00:00Z", "last_update_date": "2025-12-19T11:52:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/simulect-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "71868", "name": "Simulect : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:03:14Z", "last_update_date": "2025-12-19T12:03:14Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/simulect-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "25860", "name": "Yargesa : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-04-10T18:57:00Z", "last_update_date": "2025-12-19T09:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/yargesa-epar-product-information_en.pdf"}, {"id": "68766", "name": "Yargesa : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-06-16T12:12:21Z", "last_update_date": "2025-12-19T12:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/yargesa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "35861", "name": "Leflunomide medac : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2010-08-05T02:00:00Z", "last_update_date": "2025-12-19T13:43:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/leflunomide-medac-epar-product-information_en.pdf"}, {"id": "69102", "name": "Leflunomide medac : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-04T11:58:20Z", "last_update_date": "2025-12-19T12:11:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/leflunomide-medac-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "68206", "name": "Tuzulby : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-08T16:49:55Z", "last_update_date": "2025-12-19T11:10:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tuzulby-epar-product-information_en.pdf"}, {"id": "70993", "name": "Tuzulby : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-11-04T11:11:00Z", "last_update_date": "2025-12-19T12:17:07Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tuzulby-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "27102", "name": "Pregabalin Viatris : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2015-07-31T02:00:00Z", "last_update_date": "2025-12-19T12:24:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/pregabalin-viatris-epar-product-information_en.pdf"}, {"id": "63218", "name": "Pregabalin Viatris : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2024-05-16T11:00:00Z", "last_update_date": "2025-12-19T08:56:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/pregabalin-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "19027", "name": "Replagal : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2008-11-03T01:00:00Z", "last_update_date": "2025-12-19T11:02:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/replagal-epar-product-information_en.pdf"}, {"id": "70140", "name": "Replagal : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-18T11:54:07Z", "last_update_date": "2025-12-19T12:33:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/replagal-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "10369", "name": "Shingrix : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2018-03-28T02:00:00Z", "last_update_date": "2025-12-19T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/shingrix-epar-all-authorised-presentations_en.pdf"}, {"id": "25698", "name": "Shingrix : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2018-03-28T02:00:00Z", "last_update_date": "2025-12-19T02:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/shingrix-epar-product-information_en.pdf"}, {"id": "69347", "name": "Shingrix : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-07-17T12:36:03Z", "last_update_date": "2025-12-19T13:50:30Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/shingrix-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "48900", "name": "Shingrix : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2020-09-28T14:21:00Z", "last_update_date": "2025-12-19T11:47:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/shingrix-epar-risk-management-plan_en.pdf"}, {"id": "71869", "name": "Shingrix-X-0000243671 : EPAR - Assessment report - Extension", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T12:41:11Z", "last_update_date": "2025-12-19T12:41:11Z", "reference_number": "EMADOC-1700519818-2471078", "url": "https://www.ema.europa.eu/en/documents/variation-report/shingrix-x-0000243671-epar-assessment-report-extension_en.pdf"}, {"id": "52379", "name": "Minjuvi : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2021-09-08T15:00:00Z", "last_update_date": "2025-12-19T10:55:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/minjuvi-epar-product-information_en.pdf"}, {"id": "70461", "name": "Minjuvi : EPAR - Procedural steps taken and scientific information after the authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-10-06T17:18:59Z", "last_update_date": "2025-12-19T12:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/minjuvi-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "16444", "name": "Olumiant : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-03-16T01:00:00Z", "last_update_date": "2025-12-19T16:57:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/olumiant-epar-product-information_en.pdf"}, {"id": "71870", "name": "Olumiant : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:53:04Z", "last_update_date": "2025-12-19T12:53:04Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/olumiant-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf-0"}, {"id": "71871", "name": "Metoprolol : List of nationally authorised medicinal products - PSUSA/00002039/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:47:09Z", "last_update_date": "2025-12-19T12:47:09Z", "reference_number": "EMADOC-1700519818-2771118", "url": "https://www.ema.europa.eu/en/documents/psusa/metoprolol-list-nationally-authorised-medicinal-products-psusa-00002039-202503_en.pdf"}, {"id": "71872", "name": "Metoprolol : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002039/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T12:49:53Z", "last_update_date": "2025-12-19T12:49:53Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/metoprolol-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002039-202503_en.pdf"}, {"id": "71875", "name": "Macitentan AccordPharma : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:08:09Z", "last_update_date": "2025-12-19T13:08:09Z", "reference_number": "EMA/251923/2025", "url": "https://www.ema.europa.eu/en/documents/overview/macitentan-accordpharma-epar-medicine-overview_en.pdf"}, {"id": "71876", "name": "Macitentan AccordPharma : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:09:15Z", "last_update_date": "2025-12-19T13:09:15Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/macitentan-accordpharma-epar-risk-management-plan_en.pdf"}, {"id": "71877", "name": "Macitentan AccordPharma : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:11:10Z", "last_update_date": "2025-12-19T13:11:10Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/macitentan-accordpharma-epar-product-information_en.pdf"}, {"id": "71878", "name": "Macitentan AccordPharma : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:12:19Z", "last_update_date": "2025-12-19T13:12:19Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/macitentan-accordpharma-epar-all-authorised-presentations_en.pdf"}, {"id": "71879", "name": "Macitentan AccordPharma : EPAR - Public assessment report", "type": "assessment-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T13:13:14Z", "last_update_date": "2025-12-19T13:13:14Z", "reference_number": "EMA/CHMP/216792/2025", "url": "https://www.ema.europa.eu/en/documents/assessment-report/macitentan-accordpharma-epar-public-assessment-report_en.pdf"}, {"id": "60975", "name": "Product information URLs for member states", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2018-09-27T11:05:53Z", "last_update_date": "2025-12-19T13:30:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/product-information-urls-member-states_en.xls"}, {"id": "68207", "name": "Tuzulby : EPAR - All authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2025-05-08T16:52:13Z", "last_update_date": "2025-12-19T13:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/tuzulby-epar-all-authorised-presentations_en.pdf"}, {"id": "45256", "name": "Rotarix : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2019-08-14T14:58:00Z", "last_update_date": "2025-12-19T15:27:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/rotarix-epar-risk-management-plan_en.pdf"}, {"id": "71880", "name": "Rifampicin : List of nationally authorised medicinal products - PSUSA/00002640/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:27:19Z", "last_update_date": "2025-12-19T13:27:19Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/rifampicin-list-nationally-authorised-medicinal-products-psusa-00002640-202503_en.pdf"}, {"id": "71881", "name": "Rifampicin : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002640/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T13:32:53Z", "last_update_date": "2025-12-19T13:32:53Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/rifampicin-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002640-202503_en.pdf"}, {"id": "71882", "name": "Olumiant : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T14:48:16Z", "last_update_date": "2025-12-19T14:48:16Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/olumiant-epar-product-information-tracked-changes_en.docx"}, {"id": "71883", "name": "Rocuronium : List of nationally authorised medicinal products - PSUSA/00002656/202502", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T14:48:22Z", "last_update_date": "2025-12-19T14:48:22Z", "reference_number": "EMADOC-1700519818-2775133", "url": "https://www.ema.europa.eu/en/documents/psusa/rocuronium-list-nationally-authorised-medicinal-products-psusa-00002656-202502_en.pdf"}, {"id": "71884", "name": "Rocuronium : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002656/202502", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T14:50:51Z", "last_update_date": "2025-12-19T14:50:51Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/rocuronium-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002656-202502_en.pdf"}, {"id": "11519", "name": "Tremfya : EPAR - Medicine overview", "type": "overview", "status": "unknown", "consultation_date": "", "publish_date": "2017-11-30T01:00:00Z", "last_update_date": "2025-12-19T11:59:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/overview/tremfya-epar-medicine-overview_en.pdf"}, {"id": "49890", "name": "Tremfya : EPAR - Risk management plan", "type": "rmp", "status": "unknown", "consultation_date": "", "publish_date": "2021-01-22T10:29:00Z", "last_update_date": "2025-12-19T11:36:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/rmp/tremfya-epar-risk-management-plan_en.pdf"}, {"id": "17468", "name": "Tremfya : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2017-11-30T01:00:00Z", "last_update_date": "2025-12-19T16:31:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/tremfya-epar-product-information_en.pdf"}, {"id": "41843", "name": "Tremfya : EPAR - All Authorised presentations", "type": "all-authorised-presentations", "status": "unknown", "consultation_date": "", "publish_date": "2017-11-30T01:00:00Z", "last_update_date": "2025-12-19T13:00:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/all-authorised-presentations/tremfya-epar-all-authorised-presentations_en.pdf"}, {"id": "69993", "name": "Tremfya : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-09-08T13:53:43Z", "last_update_date": "2025-12-19T16:15:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/tremfya-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71885", "name": "Tremfya-X-0000248626 : EPAR - Assessment report - Variation", "type": "variation-report", "status": "Adopted", "consultation_date": "", "publish_date": "2025-12-19T15:07:42Z", "last_update_date": "2025-12-19T15:07:42Z", "reference_number": "EMADOC-1700519818-2583818", "url": "https://www.ema.europa.eu/en/documents/variation-report/tremfya-x-0000248626-epar-assessment-report-variation_en.pdf"}, {"id": "71886", "name": "Tremfya : EPAR - Statement indicating compliance with the agreed completed paediatric investigation plan", "type": "pip-compliance", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:12:46Z", "last_update_date": "2025-12-19T15:12:46Z", "reference_number": "EMADOC-1700519818-2494684", "url": "https://www.ema.europa.eu/en/documents/pip-compliance/tremfya-epar-statement-indicating-compliance-agreed-completed-paediatric-investigation-plan_en.pdf"}, {"id": "71887", "name": "Selegiline : List of nationally authorised medicinal products - PSUSA/00002688/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:18:31Z", "last_update_date": "2025-12-19T15:18:31Z", "reference_number": "EMADOC-1700519818-2775121", "url": "https://www.ema.europa.eu/en/documents/psusa/selegiline-list-nationally-authorised-medicinal-products-psusa-00002688-202503_en.pdf"}, {"id": "71888", "name": "Selegiline : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002688/202503", "type": "psusa", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:20:02Z", "last_update_date": "2025-12-19T15:20:02Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/psusa/selegiline-cmdh-scientific-conclusions-grounds-variation-amendments-product-information-timetable-implementation-psusa-00002688-202503_en.pdf"}, {"id": "69897", "name": "Attrogy : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2025-08-28T16:29:07Z", "last_update_date": "2025-12-19T15:28:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/attrogy-epar-product-information_en.pdf"}, {"id": "71889", "name": "Attrogy : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T15:28:27Z", "last_update_date": "2025-12-19T15:28:27Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/attrogy-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "55558", "name": "Technology Capability Investment Plan to 2028 - Becoming a digital hub for the European medicines regulator network", "type": "report", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T10:45:00Z", "last_update_date": "2025-12-19T10:45:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/report/technology-capability-investment-plan-2028-becoming-digital-hub-european-medicines-regulator-network_en.pdf"}, {"id": "63601", "name": "Fabhalta : EPAR - Product information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2024-06-14T11:11:01Z", "last_update_date": "2025-12-19T13:27:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/fabhalta-epar-product-information_en.pdf"}, {"id": "66907", "name": "Fabhalta : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-20T16:24:17Z", "last_update_date": "2025-12-19T16:20:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/fabhalta-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "36422", "name": "Avastin : EPAR - Procedural steps taken and scientific information after authorisation (archive)", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-17T15:08:00Z", "last_update_date": "2025-12-19T17:08:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/avastin-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf"}, {"id": "5223", "name": "Avastin : EPAR - Product Information", "type": "product-information", "status": "unknown", "consultation_date": "", "publish_date": "2009-09-17T02:00:00Z", "last_update_date": "2025-12-19T12:02:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information/avastin-epar-product-information_en.pdf"}, {"id": "66920", "name": "Avastin : EPAR - Procedural steps taken and scientific information after authorisation", "type": "procedural-steps-after", "status": "unknown", "consultation_date": "", "publish_date": "2025-02-24T10:35:59Z", "last_update_date": "2025-12-19T12:03:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/procedural-steps-after/avastin-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf"}, {"id": "71891", "name": "Avastin-PSUSA-00000403-202502 : EPAR - Scientific conclusions and grounds for the variation to the terms of the marketing authorisation", "type": "scientific-conclusion", "status": "unknown", "consultation_date": "", "publish_date": "2025-12-19T16:39:48Z", "last_update_date": "2025-12-19T16:39:48Z", "reference_number": "EMADOC-1700519818-2470418", "url": "https://www.ema.europa.eu/en/documents/scientific-conclusion/avastin-psusa-00000403-202502-epar-scientific-conclusions-grounds-variation-terms-marketing-authorisation_en.pdf"}, {"id": "67978", "name": "Avastin : EPAR – Product information - tracked changes", "type": "product-information-tracked-changes", "status": "unknown", "consultation_date": "", "publish_date": "2025-04-25T12:05:23Z", "last_update_date": "2025-12-19T16:42:00Z", "reference_number": "", "url": "https://www.ema.europa.eu/en/documents/product-information-tracked-changes/avastin-epar-product-information-tracked-changes_en.docx"}]}